Tocqueville Asset Management L.P. Organon & Co. Transaction History

Tocqueville Asset Management L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$23.31 - $28.61 $1.29 Million - $1.58 Million	-55,159 Reduced 52.58%	49,742 $1.39 Million
Q3 2022 Nov 10, 2022	SELL	$23.4 - $34.25 $131,882 - $193,033	-5,636 Reduced 5.1%	104,901 $2.46 Million
Q2 2022 Aug 12, 2022	SELL	$31.66 - $38.9 $144,401 - $177,422	-4,561 Reduced 3.96%	110,537 $3.73 Million
Q1 2022 May 16, 2022	BUY	$30.45 - $39.36 $360,741 - $466,297	11,847 Added 11.47%	115,098 $4.02 Million
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $2.06 Million - $2.66 Million	-71,694 Reduced 40.98%	103,251 $3.14 Million
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $433,114 - $539,161	-15,128 Reduced 7.96%	174,945 $5.74 Million
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $5.41 Million - $7.22 Million	190,073 New	190,073 $5.75 Million

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.